Regulation of p63 expression in primary and immortalized nasopharyngeal epithelial cells

International Journal of Oncology

Volumn 33, Issue 4, 2008, Pages 713-724

  Yip, Y L ^a   Tsao, George S W ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Differentiation; Immortalization; Nasopharyngeal epithelial cells; p63; Proliferation; Senescence

Indexed keywords

ISOPROTEIN; PROTEIN P63; RETINOIC ACID; TRANSFORMING GROWTH FACTOR BETA;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER STAGING; CARCINOGENESIS; CELL AGING; CELL CLONING; CELL DIFFERENTIATION; CELL IMMORTALIZATION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; NASOPHARYNX CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS EPITHELIUM;

CARCINOMA, SQUAMOUS CELL; CELL AGING; CELL LINE; CELL PROLIFERATION; DNA, COMPLEMENTARY; EPITHELIAL CELLS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MODELS, BIOLOGICAL; MUTATION; NASOPHARYNGEAL NEOPLASMS; RETROVIRIDAE; RNA; TRANS-ACTIVATORS; TRANSFORMING GROWTH FACTOR BETA1; TUMOR SUPPRESSOR PROTEINS;

EID: 54049083811     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo_00000057     Document Type: Article

References (35)

1. Arrowsmith CH: Structure and function in the p53 family. Cell Death Differ 6: 1169-1173, 1999.
2. Waltermann A, Kartasheva NN and Dobbelstein M: Differential regulation of p63 and p73 expression. Oncogene 22: 5686-5693, 2003.
3. Yang A, Kaghad M, Caput D and McKeon F: On the shoulders of giants: p63, p73 and the rise of p53. Trends Genet 18: 90-95, 2002.
4. Okuyama R, Ogawa E, Nagoshi H, et al: p53 homologue, p51/p63, maintains the immaturity of keratinocyte stem cells by inhibiting Notch1 activity. Oncogene 26: 4478-4488, 2007.
5. Massion PP, Taflan PM, Jamshedur Rahman SM, et al: Significance of p63 amplification and overexpression in lung cancer development and prognosis. Cancer Res 63: 7113-7121, 2003.
6. Thurfjell N, Coates PJ, Uusitalo T, et al: Complex p63 mRNA isoform expression patterns in squamous cell carcinoma of the head and neck. Int J Oncol 25: 27-35, 2004.
7. Lo KW, To KF and Huang DP: Focus on nasopharyngeal carcinoma. Cancer Cell 5: 423-428, 2004.
8. Crook T, Nicholls JM, Brooks L, O'Nions J and Allday MJ: High level expression of deltaN-p63: a mechanism for the inactivation of p53 in undifferentiated nasopharyngeal carcinoma (NPC)? Oncogene 19: 3439-3444, 2000.
9. Lo KW, Mok CH, Huang DP, et al: p53 mutation in human nasopharyngeal carcinomas. Anticancer Res 12: 1957-1963, 1992.
10. Tsao SW, Wang X, Liu Y, et al: Establishment of two immortalized nasopharyngeal epithelial cell lines using SV40 large T and HPV16E6/E7 viral oncogenes. Biochim Biophys Acta 1590: 150-158, 2002.
11. Li HM, Man C, Jin Y, et al: Molecular and cytogenetic changes involved in the immortalization of nasopharyugeal epithelial cells by telomerase. Int J Cancer 119: 1567-1576, 2006.
12. Lo AK, Huang DP, Lo KW, et al: Phenotypic alterations induced by the Hong Kong-prevalent Epstein-Barr virus-encoded LMP1 variant (2117-LMP1) in nasopharyngeal epithelial cells. Int J Cancer 109: 919-925, 2004.
13. Lo AK, Liu Y, Wang XH, et al: Alterations of biologic properties and gene expression in nasopharyngeal epithelial cells by the Epstein-Barr virus-encoded latent membrane protein 1. Lab Invest 83: 697-709, 2003.
14. Deng W, Tsao SW, Guan XY, et al: Distinct profiles of critically short telomeres are a key determinant of different chromosome aberrations in immortalized human cells: whole-genome evidence from multiple cell lines. Oncogene 23: 9090-9101, 2004.
15. Tsao SW, Mok SC, Fey EG, et al: Characterization of human ovarian surface epithelial cells immortalized by human papilloma viral oncogenes (HPV-E6E7 ORFs). Exp Cell Res 218: 499-507, 1995.
16. Yang A, Kaghad M, Wang Y, et al: p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities. Mol Cell 2: 305-316, 1998.
17. Di Como CJ, Urist MJ, Babayan I, et al: p63 expression profiles in human normal and tumor tissues. Clin Cancer Res 8: 494-501, 2002.
18. Green H, Easley K and Iuchi S: Marker succession during the development of keratinocytes from cultured human embryonic stem cells. Proc Natl Acad Sci USA 100: 15625-15630, 2003.
19. Huang DP, Ho JH, Poon YF, et al: Establishment of a cell line (NPC/HK1) from a differentiated squamous carcinoma of the nasopharynx. Int J Cancer 26: 127-132, 1980.
20. Koster MI and Roop DR: The role of p63 in development and differentiation of the epidermis. J Dermatol Sci 34: 3-9, 2004.
21. De Laurenzi V, Rossi A, Terrinoni A, et al: p63 and p73 trans-activate differentiation gene promoters in human keratinocytes. Biochem Biophys Res Commun 273: 342-346, 2000.
22. Tu CL, Chang W, Xie Z and Bikle DD: Inactivation of the calcium sensing receptor inhibits E-cadherin-mediated cell-cell adhesion and calcium-induced differentiation in human epidermal keratinocytes. J Biol Chem 283: 3519-3528, 2008.
23. Andersson M, Sjostrand J, Petersen A, Honarvar AK and Karlsson JO: Caspase and proteasome activity during staurosporin-induced apoptosis in lens epithelial cells. Invest Ophthalmol Vis Sci 41: 2623-2632, 2000.
24. Vincek V, Knowles J, Li J and Nassiri M: Expression of p63 mRNA isoforms in normal human tissue. Anticancer Res 23: 3945-3948, 2003.
25. Hu H, Xia SH, Li AD, et al: Elevated expression of p63 protein in human esophageal squamous cell carcinomas. Int J Cancer 102: 580-583, 2002.
26. King KE, Ponnamperuma RM, Yamashita T, et al: DeltaNp63 alpha functions as both a positive and a negative transcriptional regulator and blocks in vitro differentiation of murine keratinocytes. Oncogene 22: 3635-3644, 2003.
27. Moll UM and Slade N: p63 and p73: roles in development and tumor formation. Mol Cancer Res 2: 371-386, 2004.
28. Patturajan M, Nomoto S, Sommer M, et al: DeltaNp63 induces beta-catenin nuclear accumulation and signaling. Cancer Cell 1: 369-379, 2002.
29. Melino G, Lu X, Gasco M, Crook T and Knight RA: Functional regulation of p73 and p63: development and cancer. Trends Biochem Sci 28: 663-670, 2003.
30. Sasaki Y, Ishida S, Morimoto I, et al: The p53 family member genes are involved in the Notch signal pathway. J Biol Chem 277: 719-724, 2002.
31. Rocco JW, Leong CO, Kuperwasser N, DeYoung MP and Ellisen LW: p63 mediates survival in squamous cell carcinoma by suppression of p73-dependent apoptosis. Cancer Cell 9: 45-56, 2006.
32. Westfall MD, Mays DJ, Sniezek JC and Pietenpol JA: The Delta Np63 alpha phosphoprotein binds the p21 and 14-3-3 sigma promoters in vivo and has transcriptional repressor activity that is reduced by Hay-Wells syndrome-derived mutations. Mol Cell Biol 23: 2264-2276, 2003.
33. Morgunkova AA: The p53 gene family: control of cell proliferation and developmental programs. Biochemistry (Mosc) 70: 955-971, 2005.
34. Elisei R, Vivaldi A, Agate L, et al: All-trans-retinoic acid treatment inhibits the growth of retinoic acid receptor beta messenger ribonucleic acid expressing thyroid cancer cell lines but does not reinduce the expression of thyroid-specific genes. J Clin Endocrinol Metab 90: 2403-2411, 2005.
35. Hong WK, Endicott J, Itri LM, et al: 13-cis-retinoic acid in the treatment of oral leukoplakia. N Engl J Med 315: 1501-1505, 1986.